Navigation Links
Biodel Inc. Announces the Completion of Its Two Pivotal Trials and the Release of EASD Abstracts Containing Additional Interim Data From Its VIAject(TM) Program
Date:7/16/2008

tudies has been locked.

About VIAject(TM)

VIAject(TM) is an ultra rapid-acting injectable human insulin intended for meal-time use by patients with Type 1 or Type 2 diabetes. In Phase I and Phase II clinical trials, VIAject(TM) has been shown to have a more rapid onset of activity than those reported for the existing rapid-acting insulin analogs. As a result, VIAject(TM) may be safer, require a lower dose and promote weight loss when compared to currently marketed meal-time insulins. VIAject(TM) has been tested in two pivotal Phase III clinical trials, which compared the effects of VIAject(TM) to Humulin(R) R, the leading recombinant human insulin.

About Biodel Inc.

Biodel Inc. is a specialty biopharmaceutical company focused on the development and commercialization of innovative treatments for endocrine disorders, such as diabetes and osteoporosis. Biodel's product candidates are developed by using VIAdel(TM) technology, which reformulates existing FDA-approved peptide drugs. The Company's lead product candidate, VIAject(TM), is an ultra rapid-acting injectable meal-time insulin in development for use by patients with Type 1 or Type 2 diabetes. VIAject(TM) has been tested in two pivotal Phase III clinical trials. Biodel's pipeline also includes VIAtab(TM) a sublingual tablet formulation of insulin in the Phase I stage of clinical testing, and two pre-clinical osteoporosis product candidates. For further information regarding Biodel, please visit the Company's website at http://www.biodel.com.

Safe Harbor

This press release contains forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. All statements, other than statements of historical facts, including statements regarding our strategy, future operations, future clinical trial results, future financial position, future revenues, projected costs, prospects, plans and objectives
'/>"/>

SOURCE Biodel Inc.
Copyright©2008 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3 4 5

Related medicine technology :

1. Biodel Inc. Completes Enrollment of Two Pivotal Phase III Clinical Trials of VIAject(TM) and Plans Manufacturing Facility for VIAject(TM)
2. Biodel Inc. Expands Ongoing Phase III VIAject(TM) Clinical Trials Into Europe
3. PTC Therapeutics Announces $25 Million Award From Cystic Fibrosis Foundation Therapeutics for Development of PTC124
4. MAP Pharmaceuticals Announces Publication of MAP0004 Study in Current Medical Research and Opinion
5. Alfacell Announces ONCONASE(R) Distribution and Marketing Agreement with Megapharm for Israel
6. Echo Therapeutics Announces Publication of Positive Clinical Data for its Symphony Transdermal Continuous Glucose Monitoring System in Journal of Diabetes Science and Technology
7. Nile Therapeutics Announces Dosing in Phase IIa Study of CD-NP in Heart Failure Patients
8. Insmed Announces First Human Bioequivalence Data for a Follow-on Biologic by a U.S. Company
9. BioCryst Announces Initiation of Phase II Study of Intramuscular Peramivir for the Treatment of Seasonal Influenza
10. Sosei Announces Completion of Phase III Trial for NorLevo(R)
11. Arena Pharmaceuticals Announces Positive Phase 1b Clinical Trial Results of APD791 for the Treatment of Arterial Thrombosis

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/6/2009)...RNewswire-FirstCall/ -- Caraco Pharmaceutical Labo...orolac tromethamine ophthalmic solution, 0.5% foll...dministration (FDA) for Sun Pharma,s Abbreviated N...; ophthalmic solution on the first day following p...erapeutically equivalent to Acular® Ophthalmi...
(Date:11/6/2009)... America,s Specialty Me...p of mid-market and smaller innovator pharmaceutic...3962, the "Affordable Health Care for America Act,...ese smaller companies fear that the cumulative eff...er their efforts to bring new medicines to market....
(Date:11/6/2009)...Nov. 6 Facet Solutions, Inc. annou...of Archus Orthopedics. The acquisition creates an ...s, intellectual property and clinical experience i...r patients suffering from lumbar spinal stenosis,"...f Pardo. "This consolidation further strengthens ...
Breaking Medicine Technology:Caraco Pharmaceutical Laboratories, Ltd. Markets Generic Acular(R) Ophthalmic Solution 2Statement of America's Specialty Medicines Companies On House Health Care Bill (H.R. 3962) 2Facet Solutions Acquires Archus Orthopedics 2Frost 26 Sullivan Examines the Key Challenges in the European Non Invasive Ventilation Market 52207 1Frost 26 Sullivan Examines the Key Challenges in the European Non Invasive Ventilation Market 52207 2PTS Inc Subsidiary Disability Access Corporation Announces 24535 000 in New Contracts and Inspection Orders for July 2009 52204 1PTS Inc Subsidiary Disability Access Corporation Announces 24535 000 in New Contracts and Inspection Orders for July 2009 52204 2Owensboro Medical Health System Announces Results of Its Modified Dutch Auction Tender Offer 52201 1Owensboro Medical Health System Announces Results of Its Modified Dutch Auction Tender Offer 52201 2
...AS, July 15 A man suffering a heart,attack recent...ER and was,eventually treated with an angioplasty ...n lab in 28 minutes. The procedure, performed by D...at Presbyterian, involved using a,tiny balloon to ...,importance of providing treatments in a safe, rap...
...eeds to Fund Completion of Phase III Trials of Lig...d Metastatic Colorectal Cancer and Phase I/II ...tudies, BELLEVUE, Wash., July 15 Light Sciences ...eloping Light Infusion Therapy(TM),(Litx(TM)) to t...that it,has raised $40.1 million in a Series C rou...
Other Medicine Technology:Record 'Door-to-Balloon' Time at Presbyterian Hospital of Dallas 2Light Sciences Oncology Raises $40.1 Million in Series C Financing 2
(Date:11/7/2009)...ewswire/ -- Speaker Nancy Pelosi spoke on the Hou...able Health Care for America Act. The House will ...the Speaker,s remarks. ,, "Madam Speaker, toda...ation and for American families. For nearly a cen...phy -- as far back as Teddy Roosevelt -- have call...
(Date:11/7/2009)...e/ -- Members of the AMA are trying a last-minute ...ding the AMA,s support of HR 3962. ,, "We want... their PATIENTS, not the leadership of the AMA," s...ociation of American Physicians and Surgeons, and ...roups. ,, "If the AMA leadership ignores the p...
(Date:11/7/2009)...fe Action endorses a key vote today on the House f...er-Lipinski-Smith Amendment, an Amendment that blo...alth care reform. ,, Americans United for Life Act..."Americans United for Life Action strongly support...inski-Smith Amendment to prohibit abortion mandate...
(Date:11/7/2009)...nomic climate, many Americans are monitoring their...n what that they consider to be absolutely essenti...eves that it’s very important for overweight...mprove their health, and he is trying to make weig...gh economy by offering reasonable prices and multi...
(Date:11/6/2009)...Nov. 6 Authentidate Holding Corp. (Nasdaq: ADAT ...on Exchange and workflow management services, has ... Healthcare to be easily integrated with one of th... Definitive Homecare Solutions, CPR+(TM). Inscryb...ed Solutions Provider program, a program designed ...
Breaking Medicine News(10 mins):Health News:Pelosi: Health Legislation Founded on Key Principles for a Healthier America: Innovation, Competition and Prevention 2Health News:Pelosi: Health Legislation Founded on Key Principles for a Healthier America: Innovation, Competition and Prevention 3Health News:Pelosi: Health Legislation Founded on Key Principles for a Healthier America: Innovation, Competition and Prevention 4Health News:Americans United for Life Action Endorses a Vote for the Stupak-Ellsworth-Pitts-Kaptur-Dahlkemper-Lipinski-Smith Amendment and Sends Score Letter to House Members 2Health News:Dallas Bariatric Surgeon Offers Multiple Options for Patients Considering Weight Loss Surgery in a Rough Economy 2Health News:Dallas Bariatric Surgeon Offers Multiple Options for Patients Considering Weight Loss Surgery in a Rough Economy 3Health News:Authentidate Introduces New Interface for Inscrybe Healthcare with Definitive Homecare Solutions' CPR+ 2Health News:Authentidate Introduces New Interface for Inscrybe Healthcare with Definitive Homecare Solutions' CPR+ 3Health News:Authentidate Introduces New Interface for Inscrybe Healthcare with Definitive Homecare Solutions' CPR+ 4
...ries of facts is one thing, understanding the big ...ates that// relational memory -- the ability to ma... pieces of information – is dependent on taking a ...er (BIDMC) and Brigham and Women's Hospital (BWH),...
... to pull up its socks on health issues, lest it pa...r of chronic diseases’. If the present trend conti...ic diseases. A study conducted by Assocham an...scular disease. It is expected that 30% of the pop...
...er morning, two casual care support staff members ...ental health unit in Porirua//, New Zealand. Ea...te at the Haumietiketike‘s menial health unit. All...Health Board. Meanwhile, voices call out for polic...
...ere will be no monthly bleeding in women or menstr...ut there are still many //women who believe it to ...hange this aspect of normal healthy life. Thi...designed to eliminate periods as long as the women...
...e developed a new method of delivering drugs to fi...oparticles - which they say would be less// physic... The team at the National University of Singa...pe, are the delivery key. Led by Professor F...
...style, which puts people under constant stress, co... attacks, kidney disease// and dementia, scientist...habits such as smoking, eating a poor diet, drinki...ess can contribute to developing high blood pressu...
Other Medicine News:Health News:To Understand the Big Picture, Give It Time -- and Sleep 2Health News:To Understand the Big Picture, Give It Time -- and Sleep 3Health News:Mentally Ill Patients - Victims Of Assault By Their Caregivers 2Health News:Period Eliminating Pills 2Health News:Modern Lifestyle Could Damage Heart 2